High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
Also known as: High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma / High-Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Recruiting | 1 |
DB14922 | Tislelizumab | 2 | Recruiting | 1 |
DB06261 | Hexaminolevulinate | 4 | Not Yet Recruiting | 1 |